Skip to main content
. 2020 Sep 14;7:1242–1254. doi: 10.1016/j.toxrep.2020.08.030

Table 1.

Results of the Clinical Chemistry Evaluation.

Group ALT AST ALP TBIL CREA UREA GLUC CHOL HDL LDL BUN Pi Ca++ Na+ K+ Cl ALB TPROT A/G
(mg/kg bw/day) [U/L] [U/L] [U/L] [μmol/L] [μmol/L] [mmol/L] [mmol/L] [mmol/L] [mmol/L] [mmol/L] [mg/dL] [mmol/L] [mmol/L] [mmol/L] [mmol/L] [mmol/L] [g/L] [g/L]
Male
0 (Control) Mean 56.50 79.70 104.70 2.32 30.40 4.45 5.64 1.67 1.39 0.25 12.46 2.20 2.67 146.15 4.89 101.66 47.18 63.03 2.99
(n = 10) SD 7.98 11.76 25.15 0.35 5.21 0.79 0.23 0.18 0.12 0.08 2.22 0.15 0.04 1.63 0.38 2.43 1.15 2.09 0.26
500 Mean 50.70 82.20 104.50 2.28 30.50 4.51 5.94 1.76 1.46 0.27 12.63 2.19 2.65 146.65 4.80 101.81 46.90 62.06 3.11
(n = 10) SD 9.87 13.53 27.50 0.83 4.50 0.39 0.55 0.22 0.17 0.09 1.08 0.21 0.07 2.32 0.17 2.40 2.46 1.97 0.34
1000 Mean 46.80 82.40 103.60 2.19 28.60 4.53 5.85 1.62 1.40 0.18 12.68 2.37 2.70 146.04 5.07 100.88 47.86 65.23 2.79
(n = 10) SD 4.52 7.15 26.86 0.27 3.66 0.67 0.38 0.14 0.14 0.04 1.87 0.12 0.06 1.88 0.23 1.83 1.45 2.24 0.35
SS ** * *
2000 Mean 41.00 84.30 112.70 1.97 30.50 4.61 5.97 1.81 1.56 0.21 12.91 2.34 2.69 146.42 5.04 102.35 47.88 65.55 2.80
(n = 10) SD 6.96 12.34 19.03 0.40 2.84 0.74 0.63 0.25 0.24 0.05 2.06 0.14 0.06 2.30 0.40 2.55 1.48 3.87 0.54
SS **
Test for Significance DN NS NS NS NS NS NS NS NS DN NS DN NS NS NS NS NS NS NS
Historical Control Range 26.0–70.0 65.0–131.0 62.0–209.0 0.4–2.5 20.0–35.0 3.3–8.9 4.7–9.2 1.4–3.1 NE NE NE 1.5–2.3 2.4–2.9 141.2–148.4 4.1–5.2 96.8–103.2 40.1–47.3 59.9–70.1 1.5–2.6



Female
0 (Control) Mean 42.80 80.10 57.60 2.19 31.20 5.46 5.88 1.64 1.59 0.14 15.29 1.85 2.69 143.20 4.15 100.35 53.65 67.49 3.94
(n = 10) SD 8.77 17.93 12.91 0.45 2.78 0.75 0.50 0.24 0.22 0.03 2.10 0.23 0.08 1.16 0.19 2.11 2.56 3.72 0.44
500 Mean 41.90 80.00 57.20 2.28 32.30 5.22 5.55 1.52 1.52 0.11 14.62 1.75 2.67 143.65 4.21 100.78 54.39 67.09 4.29
(n = 10) SD 8.27 12.88 17.48 0.34 4.06 0.80 0.62 0.16 0.14 0.03 2.23 0.25 0.08 2.68 0.31 2.54 3.16 4.13 0.24
1000 Mean 34.50 78.40 52.80 1.99 31.50 4.97 5.64 1.50 1.51 0.13 13.92 1.84 2.62 142.50 4.06 99.44 53.74 67.31 4.03
(n = 10) SD 7.09 18.62 17.84 0.33 4.17 0.62 0.40 0.31 0.28 0.05 1.73 0.16 0.03 1.36 0.25 1.72 2.17 2.42 0.56
SS *
2000 Mean 35.90 81.20 57.00 1.91 32.80 5.02 6.32 1.59 1.61 0.11 14.06 1.71 2.60 143.03 4.10 101.76 53.59 67.79 3.86
(n = 10) SD 10.02 16.68 21.16 0.37 2.62 0.80 0.42 0.27 0.26 0.04 2.25 0.20 0.05 1.96 0.17 2.37 2.23 2.30 0.65
SS *
Test for Significance NS NS NS NS NS NS NS NS NS NS NS NS U NS NS NS NS NS NS
Historical Control Range 28.0–133.0 66.0–249.0 22.0–162.0 0.5–3.6 24.0–40.0 3.8–9.5 4.0–7.3 1.1–2.8 NE NE NE 0.8–2.1 2.4–2.9 140.9–146.5 3.1–4.6 97.6–105.0 43.8–57.6 56.5–78.9 1.7–3.7

Abbreviations: A/G, albumin to globulin ratio; ALB, albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Ca++, calcium; CHOL, cholesterol; Cl, chloride; CREA, creatinine; DN, Duncan's multiple range test; GLUC, glucose; HDL, high-density lipoprotein; K+, potassium; LDL, low-density lipoprotein; Na+, sodium; NE, laboratory historical control data not yet established—new parameter in accordance with OECD 408 (25 June 2018); NS, Not Significant; Pi, inorganic phosphorous; SD, standard deviation; SS, statistically significant compared to control; TBIL, total bilirubin; TPROT, total protein; U, Mann-Whitney U test versus control.

*

p < 0.05.

**

p < 0.01.